Carter Bankshares (CARE) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
4 Nov, 2026Executive summary
Q3 net income was $7.761M ($0.35 diluted EPS); adjusted net income was $7.561M, versus $5.419M and $5.711M in Q3 2025, respectively.
Nine-month net income was $122.4M, or $5.53 diluted EPS, versus $22.9M a year earlier; adjusted net income was $27.8M versus $22.3M.
Loans were $3.771B, up $36.0M QoQ; excluding the $209.5M NPL relationship sold in Q1, loans grew $163.5M, or 4.53%, YoY.
Financial highlights
Net interest income was $41.232M, up $1.282M QoQ and $7.513M YoY; provision for credit losses was $10.476M versus $2.010M in Q2 and $2.896M in Q3 2025.
Noninterest income was $4.984M, versus $28.7M in Q2, which included a $35.9M insurance transaction gain and $12.5M securities-sale loss; Q3 2025 was $5.4M.
Q3 noninterest expense was $29.5M, up $0.8M YoY; nine-month expense rose $4.5M YoY to $90.5M, including higher salaries and data processing costs.
Total assets were $4.731B, deposits $4.117B and shareholders’ equity $526.9M at quarter-end; deposits declined $80.2M QoQ and $93.0M YoY.
Outlook and guidance
Management cited a healthy lending pipeline and momentum in small business and C&I lending; construction commitments are expected to fund over the next 12–18 months as projects progress.
Strategy priorities include investing in people, infrastructure and technology, improving operations and customer experience, and expanding market presence; a new SBA 7(a) team supports small-business lending.
Funding priorities include growing lower-cost nonmaturity deposits; 81.0% of the $1.8B CD portfolio matures within 12 months and 96.0% within 24 months.
Latest events from Carter Bankshares
- Higher net interest income lifted 2022 earnings as loans grew and deposits and equity faced pressure.CARE
Q4 2022 - A $301.9M nonaccrual relationship drove 8.83% NPLs and a Q4 loss.CARE
Q4 2023 - Net income surged on nonrecurring gains, with improved asset quality and capital ratios.CARE
Q2 2026 - Earnings surged in Q1 2026 on a major loan sale, sharply improving capital and asset quality amid new legal risks.CARE
Q1 2026 - Director elections, executive pay, auditor ratification, and ESG priorities headline the 2026 proxy.CARE
Proxy filing - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 2025